SMS Lifesciences India Limited — Board Meeting, 29-05-2025: Outcome of Board Meeting

SMS Lifesciences has announced a board meeting on the approval of the financial results for the quarter and half-year ended March 31, 2025. The company posted consolidated revenue of Rs. 344.7 Cr with a profit after tax of Rs. 18.7 Cr for the year, showing strong growth. A dividend of Rs. 1.50 per share is proposed. The board approved changing the company name to "HALEOS LABS LIMITED," pending approvals. Mr. Talluri Venkata Praveen is set for reappointment as Executive Director for three years. USFDA inspection was successfully completed in May 2025.